Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - PRE-TAX INCOME
Pre-tax Income URGN - UroGen Pharma Ltd.
-98.3 M
LAST VALUE
5.18%
2 YEAR CAGR
-5.42%
5 YEAR CAGR
-40.39%
10 YEAR CAGR